Cover Image
市場調查報告書

頭頸癌:開發平台分析

Head And Neck Cancer - Pipeline Review, H2 2016

出版商 Global Markets Direct 商品編碼 351248
出版日期 內容資訊 英文 1153 Pages
訂單完成後即時交付
價格
Back to Top
頭頸癌:開發平台分析 Head And Neck Cancer - Pipeline Review, H2 2016
出版日期: 2016年10月26日 內容資訊: 英文 1153 Pages
簡介

本報告提供頭頸癌的治療藥開發平台現狀及最新更新的各開發階段比較分析,提供您企業和研究機關開發中的治療藥,治療藥評估,後期階段及中止的計劃等相關資訊。

簡介

  • 調查範圍

頭頸癌概要

治療藥的開發

  • 頭頸癌的開發中產品:概要
  • 頭頸癌的開發中產品:比較分析

頭頸癌:企業開發中的治療藥

頭頸癌:大學/機關研究中的治療藥

頭頸癌:開發中產品概況

  • 最後階段的產品
  • 臨床階段的產品
  • 初期階段的產品
  • 不明

頭頸癌:企業開發中的產品

頭頸癌:大學/機關研究中的產品

頭頸癌的治療藥的開發企業

頭頸癌:治療藥的評估

藥物簡介

頭頸癌:最近的開發平台趨勢

頭頸癌:暫停中的計劃

頭頸癌:開發中止的產品

頭頸癌:產品開發的里程碑

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC8588IDB

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx). The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Head And Neck Cancer - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Head And Neck Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 17, 73, 86, 6, 76, 18 and 2 respectively for Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 9, 6, 16 and 3 molecules, respectively for Head And Neck Cancer.

Head And Neck Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Head And Neck Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Head And Neck Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Head And Neck Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Head And Neck Cancer (Oncology)

Reasons to buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Head And Neck Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Head And Neck Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

  • Table of Contents
  • Introduction
  • Head And Neck Cancer Overview
  • Therapeutics Development
  • Head And Neck Cancer - Therapeutics under Development by Companies
  • Head And Neck Cancer - Therapeutics under Investigation by Universities/Institutes
  • Head And Neck Cancer - Pipeline Products Glance
  • Head And Neck Cancer - Products under Development by Companies
  • Head And Neck Cancer - Products under Investigation by Universities/Institutes
  • Head And Neck Cancer - Companies Involved in Therapeutics Development
  • Head And Neck Cancer - Therapeutics Assessment
  • Drug Profiles
  • Head And Neck Cancer - Dormant Projects
  • Head And Neck Cancer - Discontinued Products
  • Head And Neck Cancer - Product Development Milestones
  • Appendix

List of Tables

  • Number of Products under Development for Head And Neck Cancer, H2 2016
  • Number of Products under Development for Head And Neck Cancer - Comparative Analysis, H2 2016
  • Number of Products under Development by Companies, H2 2016
  • Number of Products under Development by Companies, H2 2016 (Contd..1)
  • Number of Products under Development by Companies, H2 2016 (Contd..2)
  • Number of Products under Development by Companies, H2 2016 (Contd..3)
  • Number of Products under Development by Companies, H2 2016 (Contd..4)
  • Number of Products under Development by Companies, H2 2016 (Contd..5)
  • Number of Products under Development by Companies, H2 2016 (Contd..6)
  • Number of Products under Development by Companies, H2 2016 (Contd..7)
  • Number of Products under Development by Companies, H2 2016 (Contd..8)
  • Number of Products under Development by Companies, H2 2016 (Contd..9)
  • Number of Products under Development by Companies, H2 2016 (Contd..10)
  • Number of Products under Development by Companies, H2 2016 (Contd..11)
  • Number of Products under Development by Companies, H2 2016 (Contd..12)
  • Number of Products under Development by Companies, H2 2016 (Contd..13)
  • Number of Products under Investigation by Universities/Institutes, H2 2016
  • Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1)
  • Comparative Analysis by Late Stage Development, H2 2016
  • Comparative Analysis by Clinical Stage Development, H2 2016
  • Comparative Analysis by Early Stage Development, H2 2016
  • Comparative Analysis by Unknown Stage Development, H2 2016
  • Products under Development by Companies, H2 2016
  • Products under Development by Companies, H2 2016 (Contd..1)
  • Products under Development by Companies, H2 2016 (Contd..2)
  • Products under Development by Companies, H2 2016 (Contd..3)
  • Products under Development by Companies, H2 2016 (Contd..4)
  • Products under Development by Companies, H2 2016 (Contd..5)
  • Products under Development by Companies, H2 2016 (Contd..6)
  • Products under Development by Companies, H2 2016 (Contd..7)
  • Products under Development by Companies, H2 2016 (Contd..8)
  • Products under Development by Companies, H2 2016 (Contd..9)
  • Products under Development by Companies, H2 2016 (Contd..10)
  • Products under Development by Companies, H2 2016 (Contd..11)
  • Products under Development by Companies, H2 2016 (Contd..12)
  • Products under Development by Companies, H2 2016 (Contd..13)
  • Products under Development by Companies, H2 2016 (Contd..14)
  • Products under Development by Companies, H2 2016 (Contd..15)
  • Products under Development by Companies, H2 2016 (Contd..16)
  • Products under Development by Companies, H2 2016 (Contd..17)
  • Products under Development by Companies, H2 2016 (Contd..18)
  • Products under Development by Companies, H2 2016 (Contd..19)
  • Products under Development by Companies, H2 2016 (Contd..20)
  • Products under Investigation by Universities/Institutes, H2 2016
  • Products under Investigation by Universities/Institutes, H2 2016 (Contd..1)
  • Products under Investigation by Universities/Institutes, H2 2016 (Contd..2)
  • Head And Neck Cancer - Pipeline by 3SBio Inc., H2 2016
  • Head And Neck Cancer - Pipeline by 4SC AG, H2 2016
  • Head And Neck Cancer - Pipeline by AB Science SA, H2 2016
  • Head And Neck Cancer - Pipeline by AbbVie Inc, H2 2016
  • Head And Neck Cancer - Pipeline by Accelerated Pharma, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Acceleron Pharma, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Adaptimmune Therapeutics Plc, H2 2016
  • Head And Neck Cancer - Pipeline by Aduro BioTech, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Advaxis, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Advenchen Laboratories, LLC, H2 2016
  • Head And Neck Cancer - Pipeline by Affimed GmbH , H2 2016
  • Head And Neck Cancer - Pipeline by Alchemia Limited, H2 2016
  • Head And Neck Cancer - Pipeline by Altor BioScience Corporation, H2 2016
  • Head And Neck Cancer - Pipeline by Ambrx, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Amgen Inc., H2 2016
  • Head And Neck Cancer - Pipeline by arGEN-X BV, H2 2016
  • Head And Neck Cancer - Pipeline by ArQule, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Aspyrian Therapeutics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Astellas Pharma Inc., H2 2016
  • Head And Neck Cancer - Pipeline by AstraZeneca Plc, H2 2016
  • Head And Neck Cancer - Pipeline by Atara Biotherapeutics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by ATLAB Pharma SAS, H2 2016
  • Head And Neck Cancer - Pipeline by Aura Biosciences, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by AVEO Pharmaceuticals, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Bayer AG, H2 2016
  • Head And Neck Cancer - Pipeline by Betta Pharmaceuticals Co. Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Bexion Pharmaceuticals, LLC, H2 2016
  • Head And Neck Cancer - Pipeline by Bio-Path Holdings, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by BioDiem Ltd, H2 2016
  • Head And Neck Cancer - Pipeline by Biomics Biotechnologies Co., Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Bionovis SA, H2 2016
  • Head And Neck Cancer - Pipeline by BioNTech AG, H2 2016
  • Head And Neck Cancer - Pipeline by Biotest AG, H2 2016
  • Head And Neck Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2016
  • Head And Neck Cancer - Pipeline by Boston Biomedical, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Bristol-Myers Squibb Company, H2 2016
  • Head And Neck Cancer - Pipeline by Calithera Biosciences, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by CEL-SCI Corporation, H2 2016
  • Head And Neck Cancer - Pipeline by Celgene Corporation, H2 2016
  • Head And Neck Cancer - Pipeline by Cell Medica Limited, H2 2016
  • Head And Neck Cancer - Pipeline by Cellceutix Corporation, H2 2016
  • Head And Neck Cancer - Pipeline by Celldex Therapeutics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Celprogen, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Centrose LLC, H2 2016
  • Head And Neck Cancer - Pipeline by Corvus Pharmaceuticals, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Cristal Therapeutics B.V., H2 2016
  • Head And Neck Cancer - Pipeline by Critical Outcome Technologies Inc., H2 2016
  • Head And Neck Cancer - Pipeline by CTI BioPharma Corp., H2 2016
  • Head And Neck Cancer - Pipeline by Daiichi Sankyo Company, Limited, H2 2016
  • Head And Neck Cancer - Pipeline by DNJ Pharma, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Eisai Co., Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Eleven Biotherapeutics Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Eli Lilly and Company, H2 2016
  • Head And Neck Cancer - Pipeline by EntreChem, S.L., H2 2016
  • Head And Neck Cancer - Pipeline by Etubics Corporation, H2 2016
  • Head And Neck Cancer - Pipeline by Eureka Therapeutics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by F. Hoffmann-La Roche Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Five Prime Therapeutics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by G&E Herbal Biotechnology Co., Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Genelux Corporation, H2 2016
  • Head And Neck Cancer - Pipeline by GeneSegues Inc, H2 2016
  • Head And Neck Cancer - Pipeline by Genexine, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Genmab A/S, H2 2016
  • Head And Neck Cancer - Pipeline by Genticel S.A., H2 2016
  • Head And Neck Cancer - Pipeline by GlaxoSmithKline Plc, H2 2016
  • Head And Neck Cancer - Pipeline by Gliknik, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Glycotope GmbH, H2 2016
  • Head And Neck Cancer - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Hookipa Biotech AG, H2 2016
  • Head And Neck Cancer - Pipeline by Horizon Pharma Plc, H2 2016
  • Head And Neck Cancer - Pipeline by Hutchison MediPharma Limited, H2 2016
  • Head And Neck Cancer - Pipeline by Ignyta, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Immunomedics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Immunovaccine, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Immunovative Therapies, Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Incuron, LLC, H2 2016
  • Head And Neck Cancer - Pipeline by Incyte Corporation, H2 2016
  • Head And Neck Cancer - Pipeline by Infinity Pharmaceuticals, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Innate Pharma S.A., H2 2016
  • Head And Neck Cancer - Pipeline by Inovio Pharmaceuticals, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by InteRNA Technologies B.V., H2 2016
  • Head And Neck Cancer - Pipeline by IRX Therapeutics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by ISA Pharmaceuticals B.V., H2 2016
  • Head And Neck Cancer - Pipeline by Jiangsu Kanion Pharmaceutical Co., Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Johnson & Johnson, H2 2016
  • Head And Neck Cancer - Pipeline by Kite Pharma Inc, H2 2016
  • Head And Neck Cancer - Pipeline by Kolltan Pharmaceuticals, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Kura Oncology, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Laboratoires Pierre Fabre SA, H2 2016
  • Head And Neck Cancer - Pipeline by Lakewood-Amedex Inc, H2 2016
  • Head And Neck Cancer - Pipeline by Loxo Oncology, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Lytix Biopharma AS, H2 2016
  • Head And Neck Cancer - Pipeline by Mabion SA, H2 2016
  • Head And Neck Cancer - Pipeline by Mabtech Limited, H2 2016
  • Head And Neck Cancer - Pipeline by MacroGenics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Marsala Biotech Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Mateon Therapeutics Inc, H2 2016
  • Head And Neck Cancer - Pipeline by MaxiVAX SA, H2 2016
  • Head And Neck Cancer - Pipeline by Meabco A/S, H2 2016
  • Head And Neck Cancer - Pipeline by MedImmune, LLC, H2 2016
  • Head And Neck Cancer - Pipeline by Merck & Co., Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Merck KGaA, H2 2016
  • Head And Neck Cancer - Pipeline by Merrimack Pharmaceuticals, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Millennium Pharmaceuticals Inc, H2 2016
  • Head And Neck Cancer - Pipeline by Mirati Therapeutics Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Molecular Partners AG, H2 2016
  • Head And Neck Cancer - Pipeline by Moleculin Biotech Inc, H2 2016
  • Head And Neck Cancer - Pipeline by Molplex Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by NanoCarrier Co., Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Natco Pharma Limited, H2 2016
  • Head And Neck Cancer - Pipeline by Neonc Technologies Inc, H2 2016
  • Head And Neck Cancer - Pipeline by Northwest Biotherapeutics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Novartis AG, H2 2016
  • Head And Neck Cancer - Pipeline by Omnitura Therapeutics Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Oncobiologics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Oncolys BioPharma Inc, H2 2016
  • Head And Neck Cancer - Pipeline by Oncolytics Biotech Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Onconova Therapeutics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by OncoSec Medical Incorporated, H2 2016
  • Head And Neck Cancer - Pipeline by Ono Pharmaceutical Co., Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Oryx GmbH & Co. KG, H2 2016
  • Head And Neck Cancer - Pipeline by Panacea Biotec Limited, H2 2016
  • Head And Neck Cancer - Pipeline by PCI Biotech Holding ASA, H2 2016
  • Head And Neck Cancer - Pipeline by PDS Biotechnology Corporation, H2 2016
  • Head And Neck Cancer - Pipeline by Pfizer Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Pharma Mar, S.A., H2 2016
  • Head And Neck Cancer - Pipeline by Pique Therapeutics, H2 2016
  • Head And Neck Cancer - Pipeline by PlantForm Corporation, H2 2016
  • Head And Neck Cancer - Pipeline by Plexxikon Inc., H2 2016
  • Head And Neck Cancer - Pipeline by PNP Therapeutics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Profectus BioSciences, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by ProNAi Therapeutics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Provectus Biopharmaceuticals, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by R-Pharm, H2 2016
  • Head And Neck Cancer - Pipeline by Redx Pharma Plc, H2 2016
  • Head And Neck Cancer - Pipeline by Reliance Life Sciences Pvt. Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Sanofi, H2 2016
  • Head And Neck Cancer - Pipeline by Sapvax, H2 2016
  • Head And Neck Cancer - Pipeline by Sareum Holdings Plc, H2 2016
  • Head And Neck Cancer - Pipeline by Selecta Biosciences, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Shanghai Henlius Biotech Co., Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Shenzen SiBiono GeneTech Co., Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Shionogi & Co., Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Silence Therapeutics Plc, H2 2016
  • Head And Neck Cancer - Pipeline by Sillajen Biotherapeutics, H2 2016
  • Head And Neck Cancer - Pipeline by Sinil Pharmaceutical Co., Ltd, H2 2016
  • Head And Neck Cancer - Pipeline by SuviCa Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Symphogen A/S, H2 2016
  • Head And Neck Cancer - Pipeline by SynCore Biotechnology Co., Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Taiwan Liposome Company, Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by Takara Bio Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Takis S.r.l., H2 2016
  • Head And Neck Cancer - Pipeline by Tara Immuno-Oncology Therapeutics LLC, H2 2016
  • Head And Neck Cancer - Pipeline by Tessa Therapeutics Pte Ltd, H2 2016
  • Head And Neck Cancer - Pipeline by Theravectys SA, H2 2016
  • Head And Neck Cancer - Pipeline by Tolero Pharmaceuticals, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by TyrNovo Ltd., H2 2016
  • Head And Neck Cancer - Pipeline by UbiVac, LLC, H2 2016
  • Head And Neck Cancer - Pipeline by Vaccibody AS, H2 2016
  • Head And Neck Cancer - Pipeline by VasGene Therapeutics, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Vault Pharma Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Vaxeal Holding SA, H2 2016
  • Head And Neck Cancer - Pipeline by VentiRx Pharmaceuticals, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Virttu Biologics Limited, H2 2016
  • Head And Neck Cancer - Pipeline by VLPbio, H2 2016
  • Head And Neck Cancer - Pipeline by VM Discovery, Inc., H2 2016
  • Head And Neck Cancer - Pipeline by Vyriad Inc, H2 2016
  • Head And Neck Cancer - Pipeline by Yabao Pharmaceutical Group Co., Ltd., H2 2016
  • Assessment by Monotherapy Products, H2 2016
  • Assessment by Combination Products, H2 2016
  • Number of Products by Stage and Target, H2 2016
  • Number of Products by Stage and Mechanism of Action, H2 2016
  • Number of Products by Stage and Route of Administration, H2 2016
  • Number of Products by Stage and Molecule Type, H2 2016
  • Head And Neck Cancer - Dormant Projects, H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..1), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..2), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..3), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..4), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..5), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..6), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..7), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..8), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..9), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..10), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..11), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..12), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..13), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..14), H2 2016
  • Head And Neck Cancer - Dormant Projects (Contd..15), H2 2016
  • Head And Neck Cancer - Discontinued Products, H2 2016
  • Head And Neck Cancer - Discontinued Products (Contd..1), H2 2016
  • Head And Neck Cancer - Discontinued Products (Contd..2), H2 2016

List of Figures

  • Number of Products under Development for Head And Neck Cancer, H2 2016
  • Number of Products under Development for Head And Neck Cancer - Comparative Analysis, H2 2016
  • Number of Products under Development by Companies, H2 2016
  • Number of Products under Investigation by Universities/Institutes, H2 2016
  • Comparative Analysis by Late Stage Development, H2 2016
  • Comparative Analysis by Clinical Stage Development, H2 2016
  • Comparative Analysis by Early Stage Products, H2 2016
  • Assessment by Monotherapy Products, H2 2016
  • Assessment by Combination Products, H2 2016
  • Number of Products by Top 10 Targets, H2 2016
  • Number of Products by Stage and Top 10 Targets, H2 2016
  • Number of Products by Top 10 Mechanism of Actions, H2 2016
  • Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016
  • Number of Products by Top 10 Routes of Administration, H2 2016
  • Number of Products by Stage and Top 10 Routes of Administration, H2 2016
  • Number of Products by Top 10 Molecule Types, H2 2016
  • Number of Products by Stage and Top 10 Molecule Types, H2 2016
Back to Top